Navigating the FDA’s New ANDA Filing Review Policies: What You Need to Know The US Food and Drug Administration (FDA) […]

Implementing Good Manufacturing Practice (GMP) Evidence for Drug Substance (DS) Manufacturers in Singapore In its unwavering commitment to ensuring the

Navigating the Shifting Tides of Regulatory Compliance in Life Sciences In the dynamic world of life sciences, pharmaceuticals, and medical

Predetermined Change Control Plans (PCCPs) for Machine Learning Medical Devices (MLMDs) Guiding Principles Artificial intelligence (AI) and machine learning (ML)

FDA Takes Steps to Improve Efficiency of PMR/PMC Submissions The Food and Drug Administration (FDA) has released draft guidance for

UK Responsible Person Service A Must-Have for Foreign Medical Device Manufacturers The UK Responsible Person (UKRP) is a critical partner

Comprehensive Guidelines for the Development of Drugs and Biological Products to Combat COVID-19: Industry Insights The FDA’s recommendations concentrate on

2023: A Year of Regulatory Revolution in Life Sciences 2023 was a whirlwind year for the life sciences industry, with

In the ever-evolving landscape of global healthcare, a promising update has emerged, marking a significant step forward in the journey

In the realm of life sciences, artificial intelligence (AI) has long been a cornerstone, driving advancements in drug discovery, clinical